RIGEL PHARMACEUTICALS INC Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Rigel Pharmaceuticals Inc Return On Equity for the quarter ending September 30, 2024 was -14.8 %, a 115% decline year-over-year.
  • Rigel Pharmaceuticals Inc annual Return On Equity for 2023 was 88.9 %, a 88.5% decline from 2022.
  • Rigel Pharmaceuticals Inc annual Return On Equity for 2022 was 773 %.
  • Rigel Pharmaceuticals Inc annual Return On Equity for 2021 was -31.6 %, a 39.7% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 88.9 -684 -88.5% Jan 1, 2023 Dec 31, 2023
2022 773 +804 Jan 1, 2022 Dec 31, 2022
2021 -31.6 +20.8 +39.7% Jan 1, 2021 Dec 31, 2021
2020 -52.5 +37.8 +41.9% Jan 1, 2020 Dec 31, 2020
2019 -90.3 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.